Novartis' Alcon launches Jetrea in Germany
This article was originally published in Scrip
Novartis' Alcon division has launched novel vitreomacular traction drug Jetrea (ocriplasmin) in Germany, its second European market.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.